Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center identified a cocktail of three different drugs that can be used to generate more robust ...
Our findings were actually not what we expected. As I said, our hypothesis was that the high number of cell replications required in the recipient compared to the donor would result in more mutations ...
Our laboratory, clinical and public-health research is improving the way the disease ... It is also known as chronic granulocytic, chronic myelocytic or chronic myelogenous leukemia. In Chronic ...
Which medicine is best when you are affected by cancer? This can vary from person to person. A new method can help people with a specific type of blood cancer get the best medicine for them.
Chronic lymphocytic leukemia (CLL) is a cancer of a white blood cell group called a B lymphocytes. It starts in the bone marrow tissue where these B cells are formed. While doctors aren't exactly sure ...
The treatment of chronic lymphocytic leukemia (CLL) consists of the continuous use of Bruton tyrosine kinase inhibitors (BTKis) such as ibrutinib, acalabrutinib, zanubrutinib and pirtobrutinib, or Bcl ...
Ghassan K. Abou-Alfa, MD, discusses the findings and key takeaways from the SUMMIT trial, which evaluated the use of neratinib for the treatment of patients with fibrolamellar carcinoma. Ghassan K.
Chronic lymphocytic leukemia (CLL) often causes overwhelming fatigue that does not go away with rest. A person may be able to manage fatigue due to CLL with lifestyle changes and dietary adjustments.
A study finds that staying active for 150 minutes weekly slashes the risk of 19 chronic diseases. Research at the University of Iowa reveals a clear connection between regular physical activity and ...